The North America Pain Patch Market would witness market growth of 3.7% CAGR during the forecast period (2023-2029).
Due to consumers' increasing preference for online buying over conventional ways of purchasing, e-commerce has emerged as a crucial tool for small and large enterprises globally. The pain patch has expanded as a result of various animations distributed through health applications that instruct users on how to control their pain and use cutting-edge drug delivery systems. Effective pain treatment is in high demand, not just in wealthy nations; this demand is also seen in developing nations, which helps the market expand.
It is anticipated that during the forecast period, manufacturers will ramp up their promotional efforts and that the general public will become more aware of the need for appropriate pain management products. The rise in acceptance of novel drug delivery systems for pain management with fewer side effects, the rise in diagnoses of chronic pain disorders, and the rise in cases of arthritis, cancer, and neuropathic pain are additional factors that are expected to contribute to the growth of the pain patch market during the forecast period. In addition, the market is also growing as a result of proper post-operative pain conditions counseling and approvals for innovative pain patches.
Estimates of chronic pain among U.S. adults based on the population range from 11% to 40%, with significant subgroup heterogeneity. In order to accurately determine the prevalence of chronic pain and high-impact chronic pain (i.e., chronic pain that frequently restricts life or work activities), the 2016 National Pain Strategy called for more accurate prevalence estimates. This would help in introducing & implementing population-wide pain interventions. The CDC examined the 2016 National Health Interview Survey (NHIS) data to estimate the prevalence of chronic pain and high-impact chronic pain in the United States. These factors are increasing market growth.
The US market dominated the North America Pain Patch Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $1,610.9 million by 2029. The Canada market is estimated to grow at a CAGR of 6.1% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 5.1% during (2023 - 2029).
Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Type, the market is segmented into Prescription Medicines and OTC Medicines. Based on Product Type, the market is segmented into Non-Opioid Patches and Opioid Patches. Based on Non-Opioid Patches Type, the market is segmented into Nonsteroidal Anti-Inflammatory Drugs, Methyl Salicylate, Lidocaine and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Pain Patch Market is Projected to reach USD 6.4 Billion by 2029, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include NEXGEL, Inc. Viatris, Inc. Johnson & Johnson. Teva Pharmaceutical Industries Ltd. Grunenthal GmbH. Sorrento Therapeutics, Inc. Hisamitsu Pharmaceutical Co. Inc. Endo International PLC. Purdue Pharma L.P. Amneal Pharmaceuticals, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Type
- Prescription Medicines
- OTC Medicines
By Product Type
- Non-Opioid Patches
- Nonsteroidal Anti-Inflammatory Drugs
- Methyl Salicylate
- Lidocaine
- Others
- Opioid Patches
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- NEXGEL, Inc.
- Viatris, Inc.
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Grunenthal GmbH
- Sorrento Therapeutics, Inc.
- Hisamitsu Pharmaceutical Co. Inc.
- Endo International PLC
- Purdue Pharma L.P.
- Amneal Pharmaceuticals, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pain Patch Market, by Distribution Channel
1.4.2 North America Pain Patch Market, by Type
1.4.3 North America Pain Patch Market, by Product Type
1.4.4 North America Pain Patch Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Pain Patch Market by Distribution Channel
3.1 North America Drug Stores & Retail Pharmacies Market by Country
3.2 North America Hospital Pharmacies Market by Country
3.3 North America Online Providers Market by Country
Chapter 4. North America Pain Patch Market by Type
4.1 North America Prescription Medicines Market by Country
4.2 North America OTC Medicines Market by Country
Chapter 5. North America Pain Patch Market by Product Type
5.1 North America Non-Opioid Patches Market by Country
5.2 North America Pain Patch Market by Non-Opioid Patches Type
5.2.1 North America Nonsteroidal Anti-Inflammatory Drugs Market by Country
5.2.2 North America Methyl Salicylate Market by Country
5.2.3 North America Lidocaine Market by Country
5.2.4 North America Others Market by Country
5.3 North America Opioid Patches Market by Country
Chapter 6. North America Pain Patch Market by Country
6.1 US Pain Patch Market
6.1.1 US Pain Patch Market by Distribution Channel
6.1.2 US Pain Patch Market by Type
6.1.3 US Pain Patch Market by Product Type
6.1.3.1 US Pain Patch Market by Non-Opioid Patches Type
6.2 Canada Pain Patch Market
6.2.1 Canada Pain Patch Market by Distribution Channel
6.2.2 Canada Pain Patch Market by Type
6.2.3 Canada Pain Patch Market by Product Type
6.2.3.1 Canada Pain Patch Market by Non-Opioid Patches Type
6.3 Mexico Pain Patch Market
6.3.1 Mexico Pain Patch Market by Distribution Channel
6.3.2 Mexico Pain Patch Market by Type
6.3.3 Mexico Pain Patch Market by Product Type
6.3.3.1 Mexico Pain Patch Market by Non-Opioid Patches Type
6.4 Rest of North America Pain Patch Market
6.4.1 Rest of North America Pain Patch Market by Distribution Channel
6.4.2 Rest of North America Pain Patch Market by Type
6.4.3 Rest of North America Pain Patch Market by Product Type
6.4.3.1 Rest of North America Pain Patch Market by Non-Opioid Patches Type
Chapter 7. Company Profiles
7.1 NEXGEL, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Viatris, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Grünenthal GmbH
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trials:
7.6 Sorrento Therapeutics, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expenses
7.7 Hisamitsu Pharmaceutical Co. Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Recent strategies and developments:
7.7.3.1 Product Launches and Product Expansions:
7.8 Endo International PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expense
7.9 Purdue Pharma L.P.
7.9.1 Company Overview
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.1 Approvals & Trials:
TABLE 1 North America Pain Patch Market, 2019 - 2022, USD Million
TABLE 2 North America Pain Patch Market, 2023 - 2029, USD Million
TABLE 3 North America Pain Patch Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 North America Pain Patch Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 5 North America Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Drug Stores & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Pain Patch Market by Type, 2019 - 2022, USD Million
TABLE 12 North America Pain Patch Market by Type, 2023 - 2029, USD Million
TABLE 13 North America Prescription Medicines Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Prescription Medicines Market by Country, 2023 - 2029, USD Million
TABLE 15 North America OTC Medicines Market by Country, 2019 - 2022, USD Million
TABLE 16 North America OTC Medicines Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Pain Patch Market by Product Type, 2019 - 2022, USD Million
TABLE 18 North America Pain Patch Market by Product Type, 2023 - 2029, USD Million
TABLE 19 North America Non-Opioid Patches Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Non-Opioid Patches Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Pain Patch Market by Non-Opioid Patches Type, 2019 - 2022, USD Million
TABLE 22 North America Pain Patch Market by Non-Opioid Patches Type, 2023 - 2029, USD Million
TABLE 23 North America Nonsteroidal Anti-Inflammatory Drugs Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Nonsteroidal Anti-Inflammatory Drugs Market by Country, 2023 - 2029, USD Million
TABLE 25 North America Methyl Salicylate Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Methyl Salicylate Market by Country, 2023 - 2029, USD Million
TABLE 27 North America Lidocaine Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Lidocaine Market by Country, 2023 - 2029, USD Million
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 31 North America Opioid Patches Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Opioid Patches Market by Country, 2023 - 2029, USD Million
TABLE 33 North America Pain Patch Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Pain Patch Market by Country, 2023 - 2029, USD Million
TABLE 35 US Pain Patch Market, 2019 - 2022, USD Million
TABLE 36 US Pain Patch Market, 2023 - 2029, USD Million
TABLE 37 US Pain Patch Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 38 US Pain Patch Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 39 US Pain Patch Market by Type, 2019 - 2022, USD Million
TABLE 40 US Pain Patch Market by Type, 2023 - 2029, USD Million
TABLE 41 US Pain Patch Market by Product Type, 2019 - 2022, USD Million
TABLE 42 US Pain Patch Market by Product Type, 2023 - 2029, USD Million
TABLE 43 US Pain Patch Market by Non-Opioid Patches Type, 2019 - 2022, USD Million
TABLE 44 US Pain Patch Market by Non-Opioid Patches Type, 2023 - 2029, USD Million
TABLE 45 Canada Pain Patch Market, 2019 - 2022, USD Million
TABLE 46 Canada Pain Patch Market, 2023 - 2029, USD Million
TABLE 47 Canada Pain Patch Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 48 Canada Pain Patch Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 49 Canada Pain Patch Market by Type, 2019 - 2022, USD Million
TABLE 50 Canada Pain Patch Market by Type, 2023 - 2029, USD Million
TABLE 51 Canada Pain Patch Market by Product Type, 2019 - 2022, USD Million
TABLE 52 Canada Pain Patch Market by Product Type, 2023 - 2029, USD Million
TABLE 53 Canada Pain Patch Market by Non-Opioid Patches Type, 2019 - 2022, USD Million
TABLE 54 Canada Pain Patch Market by Non-Opioid Patches Type, 2023 - 2029, USD Million
TABLE 55 Mexico Pain Patch Market, 2019 - 2022, USD Million
TABLE 56 Mexico Pain Patch Market, 2023 - 2029, USD Million
TABLE 57 Mexico Pain Patch Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Mexico Pain Patch Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 Mexico Pain Patch Market by Type, 2019 - 2022, USD Million
TABLE 60 Mexico Pain Patch Market by Type, 2023 - 2029, USD Million
TABLE 61 Mexico Pain Patch Market by Product Type, 2019 - 2022, USD Million
TABLE 62 Mexico Pain Patch Market by Product Type, 2023 - 2029, USD Million
TABLE 63 Mexico Pain Patch Market by Non-Opioid Patches Type, 2019 - 2022, USD Million
TABLE 64 Mexico Pain Patch Market by Non-Opioid Patches Type, 2023 - 2029, USD Million
TABLE 65 Rest of North America Pain Patch Market, 2019 - 2022, USD Million
TABLE 66 Rest of North America Pain Patch Market, 2023 - 2029, USD Million
TABLE 67 Rest of North America Pain Patch Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 68 Rest of North America Pain Patch Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 69 Rest of North America Pain Patch Market by Type, 2019 - 2022, USD Million
TABLE 70 Rest of North America Pain Patch Market by Type, 2023 - 2029, USD Million
TABLE 71 Rest of North America Pain Patch Market by Product Type, 2019 - 2022, USD Million
TABLE 72 Rest of North America Pain Patch Market by Product Type, 2023 - 2029, USD Million
TABLE 73 Rest of North America Pain Patch Market by Non-Opioid Patches Type, 2019 - 2022, USD Million
TABLE 74 Rest of North America Pain Patch Market by Non-Opioid Patches Type, 2023 - 2029, USD Million
TABLE 75 Key Information – NEXGEL, Inc.
TABLE 76 key information – Viatris, Inc.
TABLE 77 Key information –Johnson & Johnson
TABLE 78 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information – Grünenthal GmbH
TABLE 80 Key Information – Sorrento Therapeutics, Inc.
TABLE 81 Key Information – Hisamitsu Pharmaceutical Co. Inc.
TABLE 82 Key Information – Endo International PLC
TABLE 83 Key Information – Purdue Pharma L.P.
TABLE 84 Key Information – Amneal Pharmaceuticals, INc.
List of Figures
FIG 1 Methodology for the research
FIG 2 SWOT analysis: Johnson & Johnson